薬剤疫学テキスト<br>Textbook of Pharmacoepidemiology

個数:

薬剤疫学テキスト
Textbook of Pharmacoepidemiology

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 498 p.
  • 言語 ENG
  • 商品コード 9780470029244
  • DDC分類 615.7042

基本説明

Includes a brief introduction to pharmacoepidemiology as well as sections on data sources, methodology and applications. Each chapter includes key points, case studies and essential references.

Full Description

The Textbook of Pharmacoepidemiology provides a streamlined text for evaluating the safety and effectiveness of medicines. It includes a brief introduction to pharmacoepidemiology as well as sections on data sources, methodology and applications. Each chapter includes key points, case studies and essential references.

One-step resource to gain understanding of the subject of pharmacoepidemiology at an affordable price
Gives a perspective on the subject from academia, pharmaceutical industry and regulatory agencies
Designed for students with basic knowledge of epidemiology and public health
Includes many case studies to illustrate pharmacoepidemiology in real clinical setting  

Contents

List of Contributors. Preface.

Acknowledgments.

Acknowledgments from Pharmacoepidemiology, Fourth Edition.

SECTION I INTRODUCTION TO PHARMACOEPIDEMIOLOGY.

1. What is Pharmacoepidemiology? (Brian L. Strom).

2. Study Designs Available for Pharmacoepidemiology Studies (Brian L. Strom).

3. Sample Size Considerations for Pharmacoepidemiology Studies (Brian L. Strom).

4. Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiology Studies (Sean Hennessy).

5. When Should One Perform Pharmacoepidemiology Studies? (Brian L. Strom).

6. Views from Academia, Industry, and Regulatory Agencies (Leanne K. Madre, Robert M. Califf, Robert F. Reynolds, Peter Arlett, and Jane Moseley).

SECTION II SOURCES OF PHARMACOEPIDEMIOLOGY DATA.

7. Spontaneous Reporting in the United States (Syed Rizwanuddin Ahmad, Norman S. Marks, and Roger A. Goetsch).

8. Global Drug Surveillance: The WHO Programme for International Drug Monitoring (I. Ralph Edwards, Sten Olsson, Marie Lindquist, and Bruce Hugman).

9. Case-Control Surveillance (Lynn Rosenberg, Patricia F. Coogan, and Julie R. Palmer).

10. Prescription-Event Monitoring (Saad A.W. Shakir).

11. Overview of Automated Databases in Pharmacoepidemiology (Brian L. Strom).

12. Examples of Automated Databases (Andy Stergachis, Kathleen W. Saunders, Robert L. Davis, Stephen E. Kimmel, Rita Schinnar, K. Arnold Chan, Deborah Shatin, Nigel S.B. Rawson, Sean Hennessy, Winanne Downey, MaryRose Stang, Patricia Beck, William Osei, Hubert G. Leufkens, Thomas M. MacDonald, and Joel M. Gelfand).

13. Other Approaches to Pharmacoepidemiology Studies (Brian L. Strom).

14. How Should One Perform Pharmacoepidemiology Studies? Choosing Among the Available Alternatives (Brian L. Strom).

15. Validity of Pharmacoepidemiologic Drug and Diagnosis Data (Suzanne L. West, Brian L. Strom, and Charles Poole).

SECTION III SPECIAL ISSUES IN PHARMACOEPIDEMIOLOGY METHODOLOGY.

16. Bias and Confounding in Pharmacoepidemiology (Ilona Csizmadi and Jean-Paul Collet).

17. Determining Causation from Case Reports (Judith K. Jones).

18. Molecular Pharmacoepidemiology (Stephen E. Kimmel).

19. Bioethical Issues in Pharmacoepidemiologic Research (Kevin Haynes, Jason Karlawish, and Elizabeth B. Andrews).

20. The Use of Randomized Controlled Trials for Pharmacoepidemiology Studies (Samuel M. Lesko and Allen A. Mitchell).

21. The Use of Pharmacoepidemiology to Study Beneficial Drug Effects (Brian L. Strom).

22. Pharmacoeconomics: Economic Evaluation of Pharmaceuticals (Kevin A. Schulman, Henry A. Glick, and Daniel Polsky).

23. Using Quality-of-Life Measurements in Pharmacoepidemiologic Research (Holger Schünemann, Gordon H. Guyatt, and Roman Jaeschke).

24. The Use of Meta-analysis in Pharmacoepidemiology (Carin J. Kim and Jesse A. Berlin).

25. Patient Adherence to Prescribed Drug Dosing Regimens in Ambulatory Pharmacotherapy (John Urquhart and Bernard Vrijens).

26. Novel Approaches to Pharmacoepidemiology Study Design and Statistical Analysis (Samy Suissa).

SECTION IV SPECIAL APPLICATIONS OF PHARMACOEPIDEMIOLOGY.

27. Special Applications of Pharmacoepidemiology (David Lee, Sumit R. Majumdar, Helene Levens Lipton, Stephen B. Soumerai, Sean Hennessy, Robert L. Davis, Robert T. Chen, Roselie A. Bright, Allen A. Mitchell, David J. Graham, David W. Bates, and Brian L. Strom).

28. The Future of Pharmacoepidemiology (Brian L. Strom and Stephen E. Kimmel).

Appendix A Sample Size Tables.

Appendix B Glossary.

Index.

最近チェックした商品